Advertisement

Topics

"A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults" Drugs and Medication Database

08:20 EST 23rd January 2019 | BioPortfolio

Here are the most relevant "A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults" Drugs and Medications that we have found in our database.

More Information about "A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults" on BioPortfolio

We have published hundreds of A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults news stories on BioPortfolio along with dozens of A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults Clinical Trials and PubMed Articles about A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults Companies in our database. You can also find out about relevant A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults Drugs and Medications on this site too.

Showing "Phase Clinical Trial Evaluate Immunogenicity Reactogenicity Recombinant Envelope" Drugs and Medications 1–25 of 50

Relevant

Glostrips [Nomax Inc.]

GloStrips 0.6 mg

Glostrips [Nomax Inc.]

GloStrips 1.0

Glostrips [Nomax Inc.]

GloStrips

Ful-glo [Akorn, Inc.]

Fluorescein Sodium Ophthalmic Strips, USP

Probably Relevant

Ful-glo [Akorn, Inc.]

Fluorescein Sodium Ophthalmic Strips, USP

Leukotrap [Haemonetics Manufacturing Inc]

NA

Soothee patch [Better Pain Solutions, LLC ]

Drug Facts

Possibly Relevant

Sterile cord blood collection unit [Medsep Corporation]

Sterile Cord Blood Collection UnitCode 791-08

Bacmin [Marnel Pharmaceuticals, Inc.]

BACMIN

Leukotrap wb system [Haemonetics Manufacturing Inc]

Leukotrap WB System, CPDA-1 Blood Collection Set with WBF2 Filter and Sampling System

Leukotrap wb system [Haemonetics Manufacturing Inc]

Leukotrap WB System, CPDA-1 Blood Collection Set with WBF2 Filter and Sampling System

Leukotrap wb system [Haemonetics Manufacturing Inc]

Leukotrap WB System, CPDA-1 Blood Collection Set with WBF2 Filter and Sampling System

Cpda-1 blood collection system [Haemonetics Manufacturing Inc]

CPDA-1 Blood Collection Set with Sampling System

Cpda-1 blood collection system [Haemonetics Manufacturing Inc]

CPDA-1 Blood Collection Set with Sampling System

Synagis [MedImmune, LLC]

These highlights do not include all the information needed to use SYNAGIS safely and effectively. See full prescribing information for SYNAGIS. SYNAGIS (palivizumab) injection, for intramuscular useInitial U.S. Approval: 1998

Vexa [Pharmaceutics Corporation]

Vexa-D

Leukotrap wb system [Haemonetics Manufacturing Inc]

Leukotrap WB System, CPDA-1 Blood Collection Set with WBF2 Filter and Sampling System

Leukotrap wb system [Haemonetics Manufacturing Inc]

Leukotrap WB System, CPDA-1 Blood Collection Set with WBF2 Filter and Sampling System

Iclusig [Millennium Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG(ponatinib) tablets, for oral use Initial U.S. Approval: 2012

Zinplava [Merck Sharp & Dohme Corp.]

These highlights do not include all the information needed to use ZINPLAVA safely and effectively. See full prescribing information for ZINPLAVA. ZINPLAVA™ (bezlotoxumab) injection, for intravenous use Initial U.S. Approval: 2016

Sylvant [Janssen Biotech, Inc.]

These highlights do not include all the information needed to use SYLVANT safely and effectively. See full prescribing information for SYLVANT. SYLVANT (siltuximab) for injection, for intravenous use Initial U.S. Approval: 2014

Aimovig [Amgen Inc]

These highlights do not include all the information needed to use AIMOVIG safely and effectively. See full prescribing information for AIMOVIG. AIMOVIG (erenumab-aooe) injection, for subcutaneous use Initial U.S. Approval: 2018

Trogarzo [Theratechnologies Inc.]

These highlights do not include all the information needed to use TROGARZO safely and effectively. See full prescribing information for TROGARZO. TROGARZO™ (ibalizumab-uiyk) injection, for intravenous use Initial U.S. Approval: [2018]

Nabi-hb [Biotest Pharmaceuticals Corporation]

Hepatitis B Immune Globulin (Human) Nabi-HB Solvent Detergent Treated and Filtered

Kanuma [Alexion Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use KANUMA safely and effectively. See full prescribing information for KANUMA. KANUMA (sebelipase alfa) injection, for intravenous useInitial U.S. Approval: 2015



Advertisement
Quick Search
Advertisement
Advertisement